Triton contains both mushroom mycelium and primordia (young mushroom fruit body) of Ganoderma lucidium, Cordyceps sinensis and Lentinula edodes separately cultivated into biomasses that is grown on a sterilized (autoclaved) substrates. This cultivation process ensures the tablets are free from contamination by other fungi and that pesticides and heavy metals are absent. The cultivation system is proprietary, allowing for standardized production of Triton when mixed in equal amounts. The tablets are then sealed in plastic containers.
The mixture of the three mushrooms is processed under rigorously controlled conditions that are applied to the manufacture of a conventional pharmaceutical. This ensures that each tablet contains 500mg of the standardised combination of Ganoderma lucidum, Cordyceps sinensis and Lentinula edodes.The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life.
After passing quality control testing the tablets are released for use. The choice of additives used in manufacture renders these tablets suitable for Kosher or vegetarian use.